Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GST-HG131 and GST-HG141 in Chronic Hepatitis B
NCT07709520Phase 2Recruiting
- Sponsor
- Fujian Akeylink Biotechnology Co., Ltd.
- Start
- Jul 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
A Phase 2 trial of narecovir in Chronic Hepatitis B (CHB), sponsored by Fujian Akeylink Biotechnology Co., Ltd.. Started Jul 2026; status: recruiting.
02
Drugs
narecovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07709520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07709520.